A systematic review of preclinical studies exploring the role of insulin signalling in executive function and memory.
Animal models
Comorbidity
Insulin signalling
Mental health
Systematic review
Journal
Neuroscience and biobehavioral reviews
ISSN: 1873-7528
Titre abrégé: Neurosci Biobehav Rev
Pays: United States
ID NLM: 7806090
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
27
04
2023
revised:
04
10
2023
accepted:
23
10
2023
pubmed:
2
11
2023
medline:
2
11
2023
entrez:
1
11
2023
Statut:
ppublish
Résumé
Beside its involvement in somatic dysfunctions, altered insulin signalling constitutes a risk factor for the development of mental disorders like Alzheimer's disease and obsessive-compulsive disorder. While insulin-related somatic and mental disorders are often comorbid, the fundamental mechanisms underlying this association are still elusive. Studies conducted in rodent models appear well suited to help decipher these mechanisms. Specifically, these models are apt to prospective studies in which causative mechanisms can be manipulated via multiple tools (e.g., genetically engineered models and environmental interventions), and experimentally dissociated to control for potential confounding factors. Here, we provide a narrative synthesis of preclinical studies investigating the association between hyperglycaemia - as a proxy of insulin-related metabolic dysfunctions - and impairments in working and spatial memory, and attention. Ultimately, this review will advance our knowledge on the role of glucose metabolism in the comorbidity between somatic and mental illnesses.
Identifiants
pubmed: 37913873
pii: S0149-7634(23)00404-9
doi: 10.1016/j.neubiorev.2023.105435
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
105435Informations de copyright
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.